Background: Diffusion-weighted MRI (DWI) is currently one of the fastest developing MRI-based techniques in oncology. Histogram properties from model fitting of DWI are useful features for differentiation of lesions, and classification can potentially be improved by machine learning. Purpose: To evaluate classification of malignant and benign tumors and breast cancer subtypes using support vector machine (SVM). Study Type: Prospective. SUBJECTS: Fifty-one patients with benign (n 5 23) and malignant (n 5 28) breast tumors (26 ER1, whereof six were HER21). Field Strength/Sequence: Patients were imaged with DW-MRI (3T) using twice refocused spin-echo echo-planar imaging with echo time / repetition time (TR/TE) 5 9000/86 msec, 90 3 90 matrix size, 2 3 2 mm in-plane resolution, 2.5 mm slice thickness, and 13 b-values. Assessment: Apparent diffusion coefficient (ADC), relative enhanced diffusivity (RED), and the intravoxel incoherent motion (IVIM) parameters diffusivity (D), pseudo-diffusivity (D*), and perfusion fraction (f) were calculated. The histogram properties (median, mean, standard deviation, skewness, kurtosis) were used as features in SVM (10-fold cross-validation) for differentiation of lesions and subtyping. Statistical Tests: Accuracies of the SVM classifications were calculated to find the combination of features with highest prediction accuracy. Mann-Whitney tests were performed for univariate comparisons. Results: For benign versus malignant tumors, univariate analysis found 11 histogram properties to be significant differentiators. Using SVM, the highest accuracy (0.96) was achieved from a single feature (mean of RED), or from three feature combinations of IVIM or ADC. Combining features from all models gave perfect classification. No single feature predicted HER2 status of ER 1 tumors (univariate or SVM), although high accuracy (0.90) was achieved with SVM combining several features. Importantly, these features had to include higher-order statistics (kurtosis and skewness), indicating the importance to account for heterogeneity. Data Conclusion: Our findings suggest that SVM, using features from a combination of diffusion models, improves prediction accuracy for differentiation of benign versus malignant breast tumors, and may further assist in subtyping of breast cancer. Level of Evidence: 3 Technical Efficacy: Stage 3
D iffusion-weighted magnetic resonance imaging (DW-MRI)
1 is sensitive to the random motion of water molecules. In the case of Gaussian, or free diffusion, the DW-MRI signal can be appropriately modeled as a monoexponential decay that is a function of the degree of applied diffusion weighting (b-value) and the diffusion coefficient.
In cases of non-Gaussian diffusion, the monoexponential model is commonly applied to data arising from application of two or more low and medium b-values, providing the measure of an apparent diffusion coefficient (ADC) that is influenced by the number and choice of b-values. 2 It has been shown that ADC is able to detect cancerous tissue in breast, with reduced ADC being associated with malignant tumors. [3] [4] [5] The microstructural origin of this effect is commonly attributed to increased cellular density and decreased extracellular matrix in cancer tissue compared to healthy fibroglandular tissue and benign lesions. 3, 6 At low b-values (<50 sec/mm 2 ), DW-MRI signal attenuation may also reflect blood flow in randomly oriented capillaries, with this component having a pseudodiffusion coefficient similar to that observed for true diffusion effects, but approximately one order of magnitude higher. 7 The biexponential intravoxel incoherent motion (IVIM) 7 model is formulated to capture the combined effect of microcirculation (perfusion, f, and pseudodiffusion, D*) in capillaries alongside conventional true diffusivity (D), and has been successfully applied to breast cancer, 8, 9 providing accurate identification of malignant lesions. Relative enhanced diffusivity (RED) 10 was recently introduced as a new approach in classification of breast lesions using DW-MRI data. RED is sensitive both to diffusion and microcirculation, and has been shown to correlate with early enhancement in dynamic contrast-enhanced (DCE) MRI, an indicator of high perfusion within the lesion. 10 Compared with IVIM, RED is a simpler approach, requiring fewer b-values and thereby less data and faster acquisition. This is at the cost of not providing quantitative biophysical parameters like the D* coefficient or pseudodiffusion fraction (f ), ie, it does not strictly separate microvasculature-induced diffusion from true diffusion. While it is common to report the median/mean value of derived model parameters 11, 12 as measured across a region of interest (ROI), more detailed information can potentially be obtained from analysis of the parameter histograms. 13 These additional metrics provide greater insight into the heterogeneity of tumors, which is important for the optimal planning of treatment. 14 MRI histogram features have already been associated with known prognostic factors for treatment outcome, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status. 15 Breast cancer is one of the few cancer types in which molecular classification (ER, PR, HER2) has successfully been used for the design of individualized therapies, leading to significant improvements in survival. 16, 17 The current method for determining the molecular subtype, however, currently requires invasive biopsies for histologic evaluation. Access to noninvasive prognostic and diagnostic factors derived from DW-MRI would further improve the treatment of breast cancer. In addition to simple summary statistics, combining features from different MRI models can lead to improved diagnostic classification compared to single metrics or models. 18, 19 For such purposes it is common to use a machine learning approach, such as support vector machine (SVM). 20 SVM has been used for prediction in breast cancer classification, 18, 19, 21 and showed the highest prediction accuracy among other machine-learning methods.
The study aimed to establish whether the performance of DW-MRI can be improved using SVM with a combination of diffusion-derived parameters, specifically to differentiate malignant from benign tumors, and further to predict the HER2 status in ER-positive breast cancer.
Materials and Methods

Patient Cohort
The study was approved by the Regional Committee for Medical and Health Research Ethics (REK Central Norway, 2011/568). All patients gave written informed consent prior to enrolment. The recruitment of patients for this study started in October 2013 and ended in August 2016.
Following MR examination, patients with malignant tumors underwent surgery and histopathologic analysis was performed on the resected mass. ER status was classified as positive if !1% of the cells were stained positive. 22 HER2 status was assessed by fluorescence in situ hybridization and classified as positive if the HER2 gene to chromosome ratio was !2.0. 23 Categorization of benign tumors was done by histopathologic analysis on core needle biopsies or on resected tissue if the tumor was surgically removed. For benign lesions where biopsy was not requested by the radiologist, diagnosis was based on the patient history, which included either radiographic mammography, ultrasonography, or a previous clinical MR examination with at least 6 months' follow-up at the time of recruitment. MR was performed on 61 patients; 10 datasets were excluded from analysis (seven nonsuccessful motion correction and three had Nyquist ghosting artifacts), giving 51 cases in total.
Where multiple lesions were present in the same breast, the largest was selected for analysis. Of the 51 patients, 23 tumors were classified as benign and 28 as malignant. Most of the patients with malignant tumors were ER 1 (n 5 26) and these were used for the classification of HER2 status, whereof six were HER2 1 and 20 HER2-cases. Clinical data are reported in Table 1 . A subset of 34 out of the 51 patients analyzed in this study were previously reported in a study by Teruel et al, where the RED parameter was presented for the first time.
MRI Protocols
Patients were imaged with a 3T scanner (Skyra, Siemens Healthcare, Erlangen, Germany) equipped with a 16-channel breast coil (16-channel AI Breast Coil, Siemens Healthcare).
Fat-suppressed (n 5 17 FatSat and n 5 34 SPAIR) unilateral sagittal DWI was acquired using a twice-refocused spin-echo echoplanar imaging sequence with: repetition time (TR) 9000 msec, echo time (TE) 86 msec, 90 3 90 matrix, 2 3 2 mm in-plane resolution, slice thickness 2. reversed phase-encoding direction for implementation of distortion correction arising from susceptibility boundaries. 24 A twicerefocused diffusion encoding scheme was chosen to minimize eddy current effects. 25 The patients also underwent dynamic contrastenhanced (DCE) MRI. DCE scans consisted of 3D, T 1 -weighted, nonfat-suppressed, gradient echo sequence (TR/TE 5.82/ 2.18 msec, flip angle 158, 256 3 256 matrix, in-plane resolution 0.7 3 0.7 mm, slice thickness 2.5 mm) acquisitions, collected precontrast, and at seven consecutive timepoints (with temporal resolution of 1 min) after administration of contrast agent. The DCE MR images were used for guidance of ROI selection in the DWI images. For T 2 -weighted images, nonfat-suppressed 2D turbo spin echo was performed, with TR/TE 5500/118 msec, 256 3 256 matrix, in-plane resolution 0.7 3 0.7 mm, and slice thickness 2.5 mm.
Data Analysis
PREPROCESSING. The processing workflow is presented in Fig. 1 ; Before statistical analyses and machine learning, images were corrected for geometric distortion using the phase-reversed b 5 0 s/mm 2 acquisition, using the method described by Holland et al 26 and proved for breast applications by Teruel et al. 24 In the case of displayed obvious patient motion, 3D rigid coregistration using a normalized crosscorrelation metric was performed, 27 RED5100 Á ADC b0;b1 2ADC b1;b2 ADC b1;b2
Where b 0 , b 1 , and b 2 are 0, 200, and 700 sec/mm 2 , respectively.
The IVIM parameters true diffusivity (D), pseudodiffusion fraction (f ), and pseudodiffusivity (D*) were calculated from the biexponential IVIM model 7 :
Since it can be assumed that the contribution to the signal coming from blood flow is negligible for b >200 sec/mm 2 , fitting was performed using the segmented approach Finally, D* was calculated by constrained (0-100 lm 2 /ms) Trustregion fitting to the biexponential IVIM equation using fixed values for D and f. The distortion and motion corrections were performed using the preprocessing algorithm provided in the Computational Morphometry Toolkit (CMTK, SRI International, Menlo Park, CA). Image analysis and fitting were performed using in-housedeveloped scripts in MatLab (v. 2014a MathWorks, Natick, MA).
Statistical Analysis
For each 3D ROI, voxelwise fitting for ADC, RED, and IVIM was performed to provide parameter maps of the tumors. For each of these parameters (ADC, RED, and D, f, and D* from IVIM), the mean, standard deviation, median, skewness, and kurtosis were calculated, giving five features for each of the five parameters, and thus a total of 25 features for the machine-learning analysis (Fig. 1 ). , was done to find the best combination of c and C providing highest accuracy. All the features were standardized around mean zero and unit variance prior to grid search. To prevent possible overfitting with leave-one-out crossvalidation, 28 the accuracy of the prediction was evaluated through a 10-fold crossvalidation scheme. The data were randomly divided into 10 equally sized subsets, of which nine were used for training and the remaining one for testing. The mean accuracy over 10 repetitions was calculated for all possible combinations of features to find the combination of features with the highest prediction accuracy.
Comparison between groups (benign vs. malignant, and ER1HER2-vs. ER1HER21) for selected features was done using the Mann-Whitney test with Bonferroni correction. The Mann-Whitney test was performed in MatLab (v. 2014a MathWorks), while SVM was implemented in Python programming language (v. 3.6, Python Software Foundation, https://www. python.org/) using the scikit-learn library. 29 Results Figure 3 shows parametric maps from two patients with benign and malignant tumors, respectively.
Feature Selection
For all models, it was found that including more than four features for the SVM analysis failed to increase the 10-fold prediction accuracy, and in some cases decreased it (Fig. 4) .
Prediction of Benign vs. Malignant Tumors
Default accuracy by arbitrarily assigning all tumors as malignant is 0.55 (28/51) (red dashed line, Fig. 4 ). Single feature accuracy from SVM with 10-fold crossvalidation, as well as p-values obtained from univariate analysis, are presented in Table 2 .
For ADC model features, 10-fold accuracy of 0.92 was achieved by using either ADC mean or ADC median (Table  3) RED mean alone achieved 0.96, and increasing the number of features failed to increase the accuracy.
When allowing combinations of features from all models simultaneously, an accuracy of 0.96 was achieved by combining two features ( Table 3 ). The accuracy increased to 0.98 when combining three features. Finally, perfect predictive accuracy (1.0) was reached using four features combined. This combination included of RED median , ADC std , D 
Prediction of ER1HER2-vs. ER1HER2 1 Tumors
The default accuracy by assigning all cases as ER1HER2-was 0.77 (20/26) (red dashed line, Fig. 4 ). Single-feature accuracy from SVM with 10-fold crossvalidation, as well as P-values obtained from univariate analysis, are presented in Table 4 .
The most accurate single feature from the ADC model was ADC kurtosis , with an accuracy of 0.80 (Table 5 ). The accuracy increased to 0.82 by combining ADC kurtosis with either ADC median or ADC mean .
For IVIM the single most accurate feature was D Ã std (0.77), and the accuracy increased to 0.80 using two features (multiple combinations possible). Again, a further increase in accuracy (0.82) was observed when using combinations of three features (D Ã mean , f mean , and f skewness ). RED std alone gave an accuracy of 0.72. By combining it with RED skewness the accuracy increased to 0.80. By further adding RED median into the combination, an accuracy of 0.85 was achieved.
When allowing combinations of features from all models, an accuracy of 0.85 was achieved by several combinations of two features (see Table 5 ), while four features provided the best predictive power of 0.90 for ER1HER2-and ER1HER2 1 ( Table  3 , 6 multiple combinations possible).
Discussion
There is already considerable evidence in the literature of the ability of ADC to differentiate between benign and malignant breast lesions. 3, 5, 8, 10, 30 Commonly, the ROI mean or median value is the single feature used for classification. The results from the current study show that adopting a machine-learning approach including higher-order statistical features from the ROI increases the classification accuracy of the ADC model. This indicates that the spatial distribution of ADC holds additional information on tumor heterogeneity relevant for the classification of malignancy, in agreement with previous studies. 31 Perfusion characteristics are known to be relevant for differentiation of malign and benign lesions, 8, 9 and they improve accuracy compared to using only diffusion characteristics where only first-order statistics are considered. In this work the IVIM model, which contains information about perfusion in addition to diffusion, achieved equivalent, but not higher accuracy compared with the ADC model when using two or more features. The RED model achieved its maximum accuracy for malignant vs. benign classification when using only one feature: RED mean . This result was equivalent to the best accuracy achieved for ADC and IVIM when using three or more features. Being sensitive to both microcirculation and diffusion effects, and more robust against noise than IVIM due to its simpler fitting approach, RED contains sufficient information for the classification task. Interestingly, the high single-feature accuracy for the RED model was achieved without using any higher-order statistical features associated with heterogeneity. Finally, perfect differentiation of malignant and benign lesions in our cohort was achieved when using features from ADC, IVIM, and RED models combined, indicating that these models contain complementary information that can be leveraged for clinical use (classifications). One possible interpretation is that in the combined approach, information about diffusion, perfusion, and heterogeneity contribute together in an optimized way. Furthermore, it is possible to obtain perfect classification using only lower-order statistics from all models.
DWI-derived parameters are also able to predict the HER2 status of the malignant tumors, although with lower accuracy compared to the differentiation of benign and Significant univariate differentiators are in bold font. ADC-apparent diffusion coefficient; RED-relative enhanced diffusivity; IVIM-intravoxel incoherent motion; std-standard deviation Bonferroni corrected significance threshold is p50.002 (equivalent to the p50.05 non-corrected), Bonferroni corrected high significance treshold is p50.00004 (equivalent to the p50.001 non-corrected).
malignant lesions. Here it is crucial to combine features in SVM to have predictive value, as none of the parameters itself is a significant differentiator in univariate analysis. In addition to mean/median among chosen features, skewness and kurtosis appear very important, emphasizing the importance of features associated with heterogeneity. Intratumor heterogeneity, which appear on any level (ie, genes, cells, tissue, and clinical features) pose a huge challenge for Accuracy for SVM classification with 10-fold crossvalidation, including the list of the feature combinations for each of the models with highest accuracy. The highest accuracy for a specific number of features is underlined. ADC, apparent diffusion coefficient; RED, relative enhanced diffusivity; IVIM, intravoxel incoherent motion. Scan time and fitting complexity are both significantly higher for the IVIM model, using 13 b-values in this study, than for the ADC and RED models that are based on only three b-values. Our results show that classification accuracy for malignant versus benign is already very high using REDmean alone, and the limited added clinical value of including the IVIM model must be balanced against the additional scan time and complexity of analysis. Optimal prediction of ER1HER2-and ER1HER2 1 in this study can be achieved without IVIM features, and so accuracy would not be adversely affected using a simpler acquisition.
The classification accuracy for DWI-MRI parameters to differentiate benign and malignant tumors in our study were comparable to those reported in several other studies (91% and 86.7%). 3, 10 Additionally, one of these also showed the increased accuracy when using RED over ADC shown in this study. 10 Contrary to other prior studies, 8, 9, 30 we observed no added value from consideration of IVIM over ADC. It may be because this work additionally considered ADC heterogeneity parameters, which increased the accuracy of a multisided analysis of ADC. For classification of HER2 status, varying results have been presented in the literature. Significant differentiators in (non-Bonferroni adjusted) univariate analysis of DWI parameters have been found in other studies (not exclusively considering ER 1 cases), including significantly lower mean D*, 15 higher mean ADC (P 5 0.018), 33 and a higher 90 th percentile of D (P 5 0.027) 34 for HER2 1 malignant tumors. It was reported that important parameters were mean, kurtosis, and skewness of D* for both (ER1HER2 1 and ER1HER2-), as well as ADC kurtosis (for ER1HER2 1 only). 15 By combining skewness and mean of D*, Cho et al could distinguish ER1HER2-from all other cancer subtypes (AUC 5 0.8). 15 As in our study, it is important to combine first-order with higherorder statistical parameters to obtain an optimal combination of diffusion parameters. However, other studies 35, 36 found neither correlation nor statistical differences between HER2 status and DWI-MRI parameters, as was the case in our univariate analysis. Machine learning is a common approach beyond univariate analysis, with many available algorithms. SVM was the choice in this work due to previous performance in breast cancer. 18 It is important to note that all the differing accuracies provided by diffusion parameters, such as D and ADC, arise from the choice of b-value images from our dataset; a similar effect has been analyzed in previous studies for bvalue choice.
2,37 Standardization of acquisition strategies, diffusion models, and fitting strategies remains important for comparison across studies, although a combination of parameter features across different models may ameliorate this problem. Additionally, the IVIM model is known to be noise sensitive, and several studies have explored the effect of different fitting algorithms. 38, 39 In this study, we applied the segmented fitting approach, whereas applying a Bayesian algorithm with a Gaussian or spatial prior 38 can be expected to return different histograms and thus potentially affect the machine-learning outcome. The main limitation of this study, however, is the relatively small patient cohort. Importantly, the applied 10-fold validation scheme is less prone to overfitting compared to leave one out crossvalidation. 28 A larger cohort would allow a separate test set and more rigorous validation. Thus, further validations in independent and larger cohorts are necessary to avoid overgeneralization. Our findings suggest that an SVM learning approach, using multiple features from a combination of diffusion models, improves prediction accuracy for differentiation of benign and malignant breast lesions, and may further assist in differentiating the HER2 status of ER 1 lesions. The encouraging predictive power of these combined features within this preliminary study demonstrates untapped potential of DW-MRI, and supports the inclusion of DW-MRI as part of a robust and, in the future, potentially a fully noninvasive, diagnostic process for breast cancer patients.
